• Wed, February 2, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $42 on, Feb 2nd, 2022

by: WOPRAI

Ryan Koontz Maintained (AUDC) at Strong Buy with Decreased Target to $37 on, Feb 2nd, 2022

by: WOPRAI

Kannan Venkateshwar Maintained (TMUS) at Buy and Held Target at $150 on, Feb 2nd, 2022

by: WOPRAI

Puneet Souda Maintained (TMO) at Buy and Held Target at $700 on, Feb 2nd, 2022

by: WOPRAI

Luke Sergott Maintained (TMO) at Buy with Increased Target to $710 on, Feb 2nd, 2022

by: WOPRAI

Catherine Schulte Maintained (TMO) at Buy and Held Target at $704 on, Feb 2nd, 2022

by: WOPRAI

Sung Ji Nam Maintained (TMO) at Strong Buy and Held Target at $718 on, Feb 2nd, 2022

by: WOPRAI

Vijay Kumar Maintained (TMO) at Buy with Decreased Target to $660 on, Feb 2nd, 2022

by: WOPRAI

David Hicks Initiated (TRUE) at Hold on, Feb 2nd, 2022

by: WOPRAI

Puneet Souda Maintained (TECH) at Buy with Increased Target to $144 on, Feb 2nd, 2022

by: WOPRAI

Hamza Fodderwala Maintained (TENB) at Buy with Increased Target to $63 on, Feb 2nd, 2022

by: WOPRAI

Timm Schneider Downgraded (SUN) to Hold and Increased Target to $49 on, Feb 2nd, 2022

by: WOPRAI

Joshua Pokrzywinski Maintained (SWK) at Buy with Decreased Target to $195 on, Feb 2nd, 2022

by: WOPRAI

Ryan Gilbert Initiated (STC) at Strong Buy and Held Target at $99 on, Feb 2nd, 2022

by: WOPRAI

Craig Hettenbach Maintained (ST) at Buy with Decreased Target to $71 on, Feb 2nd, 2022

by: WOPRAI

Adam Tindle Maintained (CDW) at Buy with Increased Target to $220 on, Feb 2nd, 2022

by: WOPRAI

Todd Fowler Maintained (UPS) at Buy with Increased Target to $265 on, Feb 2nd, 2022

by: WOPRAI

Fadi Chamoun Maintained (UPS) at Hold and Held Target at $225 on, Feb 2nd, 2022

by: WOPRAI

Patrick Tyler Brown Maintained (UPS) at Strong Buy with Increased Target to $275 on, Feb 2nd, 2022

by: WOPRAI

Amit Mehrotra Maintained (UPS) at Hold with Decreased Target to $216 on, Feb 2nd, 2022

by: WOPRAI

Ravi Shanker Maintained (UPS) at Sell with Increased Target to $150 on, Feb 2nd, 2022

by: WOPRAI

William Howard Maintained (UPS) at Strong Sell and Held Target at $200 on, Feb 2nd, 2022

by: WOPRAI

Christian Wetherbee Maintained (UPS) at Strong Buy with Increased Target to $275 on, Feb 2nd, 2022

by: WOPRAI

Brandon Oglenski Maintained (UPS) at Hold and Held Target at $245 on, Feb 2nd, 2022

by: WOPRAI

Rick Paterson Maintained (UPS) at Hold with Increased Target to $250 on, Feb 2nd, 2022

by: WOPRAI

Bill Selesky Upgraded (XOM) to Strong Buy and Held Target at $92 on, Feb 2nd, 2022

by: WOPRAI

Kimberly Greenberger Upgraded (UA) to Buy and Increased Target to $24 on, Feb 2nd, 2022

by: WOPRAI

Kimberly Greenberger Upgraded (UAA) to Buy and Increased Target to $24 on, Feb 2nd, 2022

by: WOPRAI

David Manthey Maintained (WM) at Hold and Held Target at $152 on, Feb 2nd, 2022

by: WOPRAI

Matthew Breese Upgraded (WBS) to Buy and Increased Target to $72 on, Feb 2nd, 2022

by: WOPRAI

Puneet Souda Maintained (WAT) at Hold with Decreased Target to $350 on, Feb 2nd, 2022

by: WOPRAI

Patrick Donnelly Maintained (WAT) at Hold with Decreased Target to $350 on, Feb 2nd, 2022

by: WOPRAI

Gregory Lewis Upgraded (VAL) to Strong Buy and Held Target at $60 on, Feb 2nd, 2022

by: WOPRAI

Dan Dolev Maintained (V) at Hold with Increased Target to $235 on, Feb 2nd, 2022

by: WOPRAI

Matthew Taylor Downgraded (ZBH) to Hold and Decreased Target to $130 on, Feb 2nd, 2022

by: WOPRAI

Dennis Ding Upgraded (ABUS) to Strong Buy and Increased Target to $5 on, Feb 2nd, 2022

by: WOPRAI

Michael Phillips Maintained (AJG) at Hold with Decreased Target to $171 on, Feb 2nd, 2022

by: WOPRAI

Melissa Fairbanks Upgraded (ARW) to Buy and Held Target at $150 on, Feb 2nd, 2022

by: WOPRAI

Aaron Hecht Maintained (ARE) at Buy with Increased Target to $230 on, Feb 2nd, 2022

by: WOPRAI

Jordan Alliger Maintained (ARCB) at Hold with Increased Target to $111 on, Feb 2nd, 2022

by: WOPRAI

Lloyd Walmsley Maintained (AMZN) at Strong Buy on, Feb 2nd, 2022

by: WOPRAI

Julien Dumoulin-Smith Upgraded (AMRC) to Strong Buy and Decreased Target to $61 on, Feb 2nd, 2022

by: WOPRAI

Umer Raffat Initiated (AMLX) at Buy on, Feb 2nd, 2022

by: WOPRAI

Erik Zwick Downgraded (BPRN) to Hold on, Feb 2nd, 2022

by: WOPRAI

John Vinh Maintained (AMD) at Buy with Increased Target to $165 on, Feb 2nd, 2022

by: WOPRAI

Hans Mosesmann Maintained (AMD) at Strong Buy with Increased Target to $200 on, Feb 2nd, 2022

by: WOPRAI

Chris Caso Maintained (AMD) at Buy with Increased Target to $160 on, Feb 2nd, 2022

by: WOPRAI

Vijay Rakesh Maintained (AMD) at Strong Buy with Increased Target to $160 on, Feb 2nd, 2022

Umer Raffat Initiated (AMLX) at Buy on, Feb 2nd, 2022

Umer Raffat of Evercore ISI Group, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Buy on, Feb 2nd, 2022.

Umer has made no other calls on AMLX in the last 4 months.



There are 3 other peers that have a rating on AMLX. Out of the 3 peers that are also analyzing AMLX, 0 agree with Umer's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Umer

  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Tuesday, February 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $36 on, Tuesday, February 1st, 2022
  • Marc Goodman of "SVB Leerink" Initiated at Buy and Held Target at $50 on, Tuesday, February 1st, 2022

Like: 👍